COO logo

COOPER COS INC/THE

COONASDAQ
πŸ† #578 by market capUS Equity
$189.24β–Ό $5.28 (βˆ’2.79%)
Simulated price
1hβ€”
24hβ–Ό 2.8%
7dβ€”
14dβ€”
30dβ€”
1yβ€”
🏦Market Cap
$14.88B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+6.1%
Slowing
πŸ“ŠGross Margin
65.5%
High
πŸ’΅FCF Margin
13.5%
Healthy
βš–οΈP/S Ratio
3.5x
Fair
Otter Score
50
Weak
No chart data available for COO.

Trading Snapshot

Day Range
$187.93 – $192.05
52-Week Range
$58.89 – $89.83
Volume
$3.17B
Avg Volume
$2.34B
Shares Outstanding
195.0M
Next Earnings
Oct 23, 2026

Fundamentals Snapshot

Annual Revenue
$4.09B
Last Q Revenue
$1.08B
P/E Ratio
63.1
P/S Ratio
3.5x
EPS (TTM)
$1.18
Dividend Yield
0.00%

Why Investors Own COO

  • βœ“High-growth profile β€” revenue up +41.9% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 79% gross margin and 23% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$4.09Bβ–² +37.1% YoY
Gross Margin (TTM)
79.3%β–² +1.3% YoY
Operating Income (TTM)
$1.31Bβ–² +37.1% YoY
Free Cash Flow (TTM)
$949Mβ–² +37.1% YoY

About COOPER COS INC/THE

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
50/100

Analyst Price Target

β“˜
Average Target
$207.03
β–² +9.4% Upside
High Target$233.22
Low Target$157.87
Based on 18 analysts

Latest News & Updates